The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease
Open accessAbstract
Increasing evidence suggests that infection with Sars-CoV-2 causes neurological deficits in a substantial proportion of affected patients. While these symptoms arise acutely during the course of infection, less is known about the possible long-term consequences for the brain. Severely affected COVID-19 cases experience high levels of proinflammatory cytokines and acute respiratory dysfunction and often require assisted ventilation. All these factors have been suggested to cause cognitive decline. Pathogenetically, this may result from direct negative effects of the immune reaction, acceleration or aggravation of pre-existing cognitive deficits, or de novo induction of a neurodegenerative disease. This article summarizes the current understanding of neurological symptoms of COVID-19 and hypothesizes that affected patients may be at higher risk of developing cognitive decline after overcoming the primary COVID-19 infection. A structured prospective evaluation should analyze the likelihood, time course, and severity of cognitive impairment following the COVID-19 pandemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The anti-inflammatory effects of guanfacine may also be useful for treating the long-term neural consequences of COVID-19”
From Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species (2020) · cites this paper as Heneka et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“where a subset of patients report sustained mental problems (Heneka et al., 2020, Pinna et al., 2020)”
From Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species (2020) · cites this paper as Heneka et al., 2020
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Self-citationNeurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Lechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S. D., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., et al. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-05965-1 · Cited by 2,668 · cited 1×
“Importantly, in about 11% of patients, anosmia occurred prior to any other clinical symptoms [3].”
BackgroundLong-term cognitive impairment and functional disability among survivors of severe sepsis.
Iwashyna, T. J., Ely, E. W., Smith, D. M., & Langa, K. M. (2010) · JAMA · doi:10.1001/jama.2010.1553 · Cited by 2,582
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
Rodriguez-Morales, A. J., Cardona-Ospina, J. A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J. P., Alvarado-Arnez, L. E., Bonilla-Aldana, D. K., Franco-Paredes, C., Henao-Martinez, A. F., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101623 · Cited by 2,542
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
Oxley, T. J., Mocco, J., Majidi, S., Kellner, C. P., Shoirah, H., Singh, I. P., Leacy, R. A. D., Shigematsu, T., Ladner, T. R., Yaeger, K., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009787 · Cited by 2,114
Cited by
Sorted by citations
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Long covid—mechanisms, risk factors, and management
Crook, H., Raza, S., Nowell, J., Young, M., & Edison, P. (2021) · BMJ · doi:10.1136/bmj.n1648 · Cited by 1,655
Neuroinvasion of SARS-CoV-2 in human and mouse brain
Song, E., Zhang, C., Israelow, B., Lu-Culligan, A., Prado, A. V., Skriabine, S., Lu, P., Weizman, O.-E., Liu, F., Dai, Y., et al. (2020) · doi:10.1101/2020.06.25.169946 · Cited by 1,064
Pathological sequelae of long-haul COVID
Mehandru, S., & Mérad, M. (2022) · Nature Immunology · doi:10.1038/s41590-021-01104-y · Cited by 675
Pathophysiology and mechanism of long COVID: a comprehensive review
Castanares‐Zapatero, D., Chalon, P. X., Kohn, L., Dauvrin, M., Detollenaere, J., de Noordhout, C. M., Jong, C. P.-D., Cleemput, I., & den Heede, K. V. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2076901 · Cited by 626
Long-term complications of COVID-19
Desai, A. D., Lavelle, M. P., Boursiquot, B. C., & Wan, E. Y. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00375.2021 · Cited by 458
COVID-19: from an acute to chronic disease? Potential long-term health consequences
Higgins, V., Sohaei, D., Diamandis, E. P., & Prassas, I. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1860895 · Cited by 429
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice
Kumari, P., Rothan, H. A., Natekar, J. P., Stone, S., Pathak, H., Strate, P. G., Arora, K., Brinton, M. A., & Kumar, M. (2021) · Viruses · doi:10.3390/v13010132 · Cited by 289
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation
Kempuraj, D., Selvakumar, G. P., Ahmed, M. E., Raikwar, S. P., Thangavel, R., Khan, A. C., Zaheer, S. A., Iyer, S. S., Burton, C., James, D., et al. (2020) · The Neuroscientist · doi:10.1177/1073858420941476 · Cited by 302
Li, L., Acioglu, C., Heary, R. F., & Elkabes, S. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.10.007 · Cited by 283
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
Salamanna, F., Maglio, M., Landini, M. P., & Fini, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.594495 · Cited by 298
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
Franke, C., Ferse, C., Kreye, J., Reincke, S. M., Sánchez-Sendín, E., Rocco, A., Steinbrenner, M., Angermair, S., Treskatsch, S., Zickler, D., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.12.022 · Cited by 282
Qin, Y., Wu, J., Chen, T., Li, J., Zhang, G., Wu, D., Zhou, Y., Zheng, N., Cai, A., Ning, Q., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci147329 · Cited by 235
Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19
Ramakrishnan, R. K., Kashour, T., Hamid, Q. A., Halwani, R., & Tleyjeh, I. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.686029 · Cited by 246
Cognitive impact of COVID-19: looking beyond the short term
Miners, J. S., Kehoe, P. G., & Love, S. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00744-w · Cited by 261
SARS-CoV-2 Infectivity and Neurological Targets in the Brain
Lukiw, W. J., Pogue, A. I., & Hill, J. M. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00947-7 · Cited by 226
Alonso-Lana, S., Marquié, M., Ruiz, A., & Boada, M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.588872 · Cited by 211
Long-Lasting Cognitive Abnormalities after COVID-19
Ferrucci, R., Dini, M., Groppo, E., Rosci, C. E., Reitano, M. R., Bai, F., Poletti, B., Brugnera, A., Silani, V., Monforte, A. D., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11020235 · Cited by 212
de Erausquin, G. A., Snyder, H. M., Carrillo, M. C., Hosseini, A. A., Brugha, T. S., & Seshadri, S. S. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12255 · Cited by 204
Brutto, Ó. H. D., Wu, S., Mera, R. M., Costa, A. F., Recalde, B. Y., & Issa, N. P. (2021) · European Journal of Neurology · doi:10.1111/ene.14775 · Cited by 187
Liu, N., Zhang, T., Ma, L., Zhang, H., Wang, H., Wei, W., Pei, H., & Li, H. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100785 · Cited by 180
Cognitive Impairment After COVID-19—A Review on Objective Test Data
Daroische, R., Hemminghyth, M. S., Eilertsen, T., Breitve, M. H., & Chwiszczuk, L. J. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.699582 · Cited by 188
Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care
Parker, A. M., Brigham, E. P., Connolly, B. A., McPeake, J. M., Agranovich, A. V., Kenes, M. T., Casey, K. S., Reynolds, C., Schmidt, K. F. R., Kim, S. Y., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00385-4 · Cited by 178
Romero-Duarte, Á., Rivera‐Izquierdo, M., de Alba, I. G.-F., Pérez-Contreras, M., Fernández‐Martínez, N. F., Ruiz-Montero, R., Serrano-Ortiz, Á., Ortiz-González-Serna, R., Salcedo-Leal, I., Jiménez-Mejías, E., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02003-7 · Cited by 161
Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study
Cecchetti, G., Agosta, F., Canu, E., Basaia, S., Barbieri, A., Cardamone, R., Bernasconi, M. P., Castelnovo, V., Cividini, C., Cursi, M., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11047-5 · Cited by 163
Boyd, R. J., Avramopoulos, D., Jantzie, L. L., & McCallion, A. S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02584-x · Cited by 168
The SARS-CoV-2 and mental health: From biological mechanisms to social consequences
Szcześniak, D. M., Gładka, A., Misiak, B., Cyran, A., & Rymaszewska, J. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110046 · Cited by 157
Wijeratne, T., & Crewther, S. G. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117179 · Cited by 146
COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study
Li, C., Liu, J., Lin, J., & Shang, H. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02052-3 · Cited by 150
COVID-19 and Diabetes: A Collision and Collusion of Two Diseases
Feldman, E. L., Savelieff, M. G., Hayek, S. S., Pennathur, S., Kretzler, M., & Pop-Busui, R. (2020) · Diabetes · doi:10.2337/dbi20-0032 · Cited by 136
Itzhaki, R. F. (2021) · Vaccines · doi:10.3390/vaccines9060679 · Cited by 126
Late Complications of COVID-19; a Systematic Review of Current Evidence.
SeyedAlinaghi, S., Afsahi, A. M., MohsseniPour, M., Behnezhad, F., Salehi, M. A., Barzegary, A., Mirzapour, P., Mehraeen, E., & Dadras, O. (2021) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v9i1.1058 · Cited by 121
Thye, A. Y.-K., Law, J. W., Tan, L. T., Pusparajah, P., Ser, H., Thurairajasingam, S., Letchumanan, V., & Lee, L. (2022) · Biology · doi:10.3390/biology11010061 · Cited by 122
Visco, V., Vitale, C., Rispoli, A., Izzo, C., Virtuoso, N., Ferruzzi, G. J., Santopietro, M., Melfi, A., Rusciano, M. R., Maglio, A., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030524 · Cited by 119
Wang, Y., Chen, L., Wu, T., Shi, H., Li, Q., Jiang, H., Zheng, D., Wang, X., Wei, Y., Zhao, Y., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01825-1 · Cited by 116
Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study
Rass, V., Beer, R., Schiefecker, A. J., Lindner, A., Kofler, M., Ianosi, B., Mahlknecht, P., Heim, B., Peball, M., Carbone, F., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15307 · Cited by 116
Inflammatory Cascade in Alzheimer’s Disease Pathogenesis: A Review of Experimental Findings
de Oliveira, J., Kucharska, E., Garcez, M. L., Rodrigues, M. S., Quevedo, J., Moreno‐González, I., & Budni, J. (2021) · Cells · doi:10.3390/cells10102581 · Cited by 110
Asadzadeh, A., Samad‐Soltani, T., & Rezaei‐Hachesu, P. (2021) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2021.100579 · Cited by 99
Käufer, C., Schreiber, C. S., Hartke, A.-S., Denden, I., Stanelle‐Bertram, S., Beck, S., Kouassi, N. M., Beythien, G., Becker, K., Schreiner, T., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103999 · Cited by 94
Sigfrid, L., Çevik, M., Jesudason, E. C., Lim, W. S., Rello, J., Amuasi, J., Bozza, F. A., Palmieri, C., Munblit, D., Holter, J. C., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043887 · Cited by 90
Mohammadi, S., Moosaie, F., & Aarabi, M. H. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02094-y · Cited by 89
Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care
Toniolo, S., the Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel, Scarioni, M., Lorenzo, F. D., Hort, J., Georges, J., Tomić, S., Nobili, F. M., & Frederiksen, K. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210335 · Cited by 86
Neurological Sequelae of COVID-19
Ahmad, S. J., Feigen, C. M., Vazquez, J. P., Kobets, A. J., & Altschul, D. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2103077 · Cited by 93
Peluso, M. J., Sans, H. M., Forman, C. A., Nylander, A. N., Ho, H.-E., Lu, S., Goldberg, S. A., Hoh, R., Tai, V., Munter, S. E., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200003 · Cited by 85
Cognitive assessment in asymptomatic COVID-19 subjects
Amalakanti, S., Arepalli, K. V. R., & Jillella, J. P. (2021) · VirusDisease · doi:10.1007/s13337-021-00663-w · Cited by 85
Arnsten, A. F. T. (2020) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2020.107327 · Cited by 75
Chen, Y., Huang, X. M., Zhang, C., An, Y., Liang, Y., Yang, Y., & Liu, Z. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03076-7 · Cited by 75
Manca, R., Marco, M. D., Ince, P. G., & Venneri, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.646908 · Cited by 77
Cognitive consequences of COVID-19: results of a cohort study from South America
Crivelli, L., Calandri, I. L., Corvalán, N., Carello, A., Keller, G., Martínez, C., Arruabarrena, M. M., & Allegri, R. (2021) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x-anp-2021-0320 · Cited by 87
Guo, P., Benito-Ballesteros, Á., Yeung, S. P., Liu, R., Saha, A., Curtis, L., Kaşer, M., Haggard, M. P., & Cheke, L. G. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.804922 · Cited by 86
Liu, S., Hossinger, A., Heumüller, S.-E., Hornberger, A., Buravlova, O., Konstantoulea, K., Müller, S. A., Paulsen, L., Rousseau, F., Schymkowitz, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25855-2 · Cited by 72
Pistarini, C., Fiabane, E., Houdayer, E., Vassallo, C., Manera, M. R., & Alemanno, F. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.643646 · Cited by 76
Veleri, S. (2021) · Experimental Brain Research · doi:10.1007/s00221-021-06244-z · Cited by 77
Nazarinia, D., Behzadifard, M., Gholampour, J., Karimi, R., & Gholampour, M. (2022) · Acta Neurologica Belgica · doi:10.1007/s13760-022-01984-3 · Cited by 73
Feng, X., Zhan, F., Luo, D., Hu, J., Wei, G., Hua, F., & Xu, G. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.08.230 · Cited by 66
Hingorani, K. S., Bhadola, S., & Cervantes-Arslanian, A. M. (2022) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.04.004 · Cited by 70
The overall impact of COVID ‐19 on healthcare during the pandemic: A multidisciplinary point of view
Sabetkish, N., & Rahmani, A. (2021) · Health Science Reports · doi:10.1002/hsr2.386 · Cited by 68
Structural Racism in the COVID-19 Pandemic: Moving Forward
Sabatello, M., Scroggins, M. J., Goto, G., Santiago, A., McCormick, A. K. H. G., Morris, K. J., Daulton, C. R., Easter, C. L., & Darien, G. (2020) · The American Journal of Bioethics · doi:10.1080/15265161.2020.1851808 · Cited by 74
SARS-CoV-2 and the Brain: What Do We Know about the Causality of ‘Cognitive COVID?
Awan, H. A., Diwan, M. N., Aamir, A., Ali, M., Giannantonio, M. D., Ullah, I., Shoib, S., & Berardis, D. D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153441 · Cited by 71
Wood, G. K., Sargent, B. F., Ahmad, Z.-U.-A., Tharmaratnam, K., Dunai, C., Egbe, F. N., Martin, N. H., Facer, B., Pendered, S. L., Rogers, H. C., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03309-8 · Cited by 67
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
Aamodt, A. H., Høgestøl, E. A., Popperud, T. H., Holter, J. C., Dyrhol‐Riise, A. M., Tonby, K., Stiksrud, B., Quist‐Paulsen, E., Berge, T., Barratt‐Due, A., et al. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10517-6 · Cited by 66
Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City
Flores-Silva, F., Garcia-Grimshaw, M. A., Valdés‐Ferrer, S. I., Vigueras-Hernández, A. P., Domínguez-Moreno, R., Tristán-Samaniego, D. P., Michel‐Chávez, A., González‐Duarte, A., Vega, F., Reyes-Melo, I., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247433 · Cited by 66
Brain fog as a Long-term Sequela of COVID-19
Nouraeinejad, A. (2022) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-022-01352-5 · Cited by 72
The role of immune activation and antigen persistence in acute and long COVID
Opsteen, S., Files, J. K., Fram, T., & Erdmann, N. B. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589231158041 · Cited by 65
Passos, F. R. S., Heimfarth, L., Monteiro, B. S., Corrêa, C. B., de Moura, T. R., Araújo, A. A. D. S., Martins‐Filho, P. R., Quintans‐Júnior, L. J., & Quintans, J. D. S. S. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108502 · Cited by 63
Chiarini, A., Gui, L., Viviani, C., Armato, U., & Prà, I. D. (2023) · Biomedicines · doi:10.3390/biomedicines11040999 · Cited by 62
Misra, D. P., Gasparyan, A. Y., & Zimba, O. (2020) · Rheumatology International · doi:10.1007/s00296-020-04694-2 · Cited by 61
Rahmati, M., Yon, D. K., Lee, S. W., Soysal, P., Koyanagi, A., Jacob, L., Li, Y., Park, J. M., Kim, Y. W., Shin, J. I., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28909 · Cited by 64
Cognitive impairment after long COVID-19: current evidence and perspectives
Li, Z., Zhang, Z., Zhang, Z., Wang, Z., & Li, H. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1239182 · Cited by 70
Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease
Rajendran, K., & Krishnan, U. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102309 · Cited by 59
Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action
Abate, G., Memo, M., & Uberti, D. (2020) · Healthcare · doi:10.3390/healthcare8030286 · Cited by 56
Schild, A., Goereci, Y., Scharfenberg, D., Klein, K., Lülling, J., Meiberth, D. U., Schweitzer, F., Stürmer, S., Zeyen, P., Şahin, D., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11444-w · Cited by 56
Cognitive symptoms after COVID-19
Altuna, M., Sánchez‐Saudinós, M. B., & Lleó, A. (2021) · Neurology Perspectives · doi:10.1016/j.neurop.2021.10.005 · Cited by 61
Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection
Mina, Y., Enose‐Akahata, Y., Hammoud, D. A., Videckis, A. J., Narpala, S., O’Connell, S. E., Carroll, R., Lin, B. C., McMahan, C. C., Nair, G., et al. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200097 · Cited by 60
Tan, P.-H., Ji, J., Hsing, C., Tan, R., & Ji, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214394 · Cited by 55
Yang, C., Chang, C., Yang, C., Pariante, C. M., & Su, K. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.04.001 · Cited by 55
Long COVID-19 Pathophysiology: What Do We Know So Far?
Tziolos, N., Ιωάννου, Π., Baliou, S., & Kofteridis, D. P. (2023) · Microorganisms · doi:10.3390/microorganisms11102458 · Cited by 56
Nawrot, J., Gornowicz‐Porowska, J., Budzianowski, J., Nowak, G., Schroeder, G., & Kurczewska, J. (2022) · Cells · doi:10.3390/cells11121897 · Cited by 62
Post COVID-19 Vaccination-Associated Neurological Complications
Assiri, S. A., Althaqafi, R. M. M., Alswat, K., Alghamdi, A., Alomairi, N. E., Nemenqani, D. M., Ibrahim, Z. S., & Elkady, A. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s343438 · Cited by 49
Neurological consequences of COVID-19
Brola, W., & Wilski, M. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00424-6 · Cited by 52
Long Noncoding RNAs as Emerging Regulators of COVID-19
Yang, Q., Fang, L., Wang, Y., Min De, Z. E. N. G., & Luo, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700184 · Cited by 51
Dolatshahi, M., Sabahi, M., & Aarabi, M. H. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02236-2 · Cited by 51
The cognitive and psychiatric subacute impairment in severe Covid-19
Serrano-Castro, P. J., Garzón-Maldonado, F. J., Naranjo, I. C., Ollero-Ortiz, A., Mínguez‐Castellanos, A., Iglesias-Espinosa, M., Baena-Palomino, P., Sánchez, V. S., Pérez, R. M. S., Rubi-Callejon, J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07559-9 · Cited by 52
He, D., Yuan, M., Dang, W., Bai, L., Yang, R., Wang, J., Ma, Y., Liu, B., Liu, S., Zhang, S., et al. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103409 · Cited by 50
Impact of COVID-19 Pandemic on Patients With Neurodegenerative Diseases
Hu, C., Chen, C., & Dong, X.-P. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.664965 · Cited by 52
How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis
Panariello, F., Cellini, L., Speciani, M., Ronchi, D. D., & Atti, A. R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.582345 · Cited by 49
Moura, A., Oliveira, D., Torres, D., Tavares-Júnior, J. W., Nóbrega, P., Braga-Neto, P., & Sobreira-Neto, M. (2022) · BMC Neurology · doi:10.1186/s12883-022-02940-7 · Cited by 36
Manzo, C., Mestres, J. S., Isetta, M., & Castagna, A. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110479 · Cited by 43
Nightmares in People with COVID-19: Did Coronavirus Infect Our Dreams?
Scarpelli, S., Nadorff, M. R., Bjorvatn, B., Chung, F., Dauvilliers, Y. A., Espie, C. A., Inoue, Y., Matsui, K., Merikanto, I., Morin, C. M., et al. (2022) · Nature and Science of Sleep · doi:10.2147/nss.s344299 · Cited by 44
Bodner, K. A., Goldberg, T. E., Devanand, D. P., & Doraiswamy, P. M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.557571 · Cited by 39
Dutta, D., Liu, J., & Xiong, H. (2022) · PubMed Central · Cited by 38
Diana, L., Regazzoni, R., Sozzi, M., Piconi, S., Borghesi, L., Lazzaroni, E., Basilico, P., Aliprandi, A., Bolognini, N., Bonardi, D. R., et al. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120511 · Cited by 39
Acute Ischemic Stroke in COVID-19: A Case-Based Systematic Review
Wijeratne, T., Sales, C., Karimi, L., & Crewther, S. G. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01031 · Cited by 41
de Andrade, E. G., Šimončičová, E., Carrier, M., Vecchiarelli, H. A., Robert, M.-È., & Tremblay, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.647378 · Cited by 39
Villadiego, J., García‐Arriaza, J., Ramírez‐Lorca, R., García‐Swinburn, R., Cabello-Rivera, D., Rosales‐Nieves, A. E., Álvarez-Vergara, M. I., Cala-Fernández, F., García‐Roldán, E., López-Ogáyar, J. L., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-022-01242-y · Cited by 41
Bidirectional Communication Between the Brain and Other Organs: The Role of Extracellular Vesicles
Zhou, W., Zhao, L., Mao, Z., Wang, Z., Zhang, Z., & Li, M. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01345-5 · Cited by 42
Calderón‐Garcidueñas, L., Torres‐Jardón, R., Franco-Lira, M., Kulesza, R. J., González-Maciel, A., Reynoso-Robles, R., Brito-Aguilar, R., García-Arreola, B., Revueltas-Ficachi, P., Barrera-Velázquez, J. A., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200891 · Cited by 40
Overtoom, E. M., Rosman, A., Zwart, J., Vogelvang, T., Schaap, T. P., van den Akker, T., & Bloemenkamp, K. W. M. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16903 · Cited by 38
Síndrome de COVID-19 persistente. Una revisión narrativa
Sampalo, A. L., Bernal-López, M. R., & Gómez‐Huelgas, R. (2021) · Revista Clínica Española · doi:10.1016/j.rce.2021.10.003 · Cited by 55
Reis, P. A., & Castro-Faria-Neto, H. C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.742158 · Cited by 40
Metadata
- Authors
- Heneka, M. T., Golenbock, D., Latz, E., Morgan, D., & Brown, R.
- Affiliations
- University of Bonn (DE)
- German Center for Neurodegenerative Diseases (DE)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Heneka, Michael T.
- Venue
- Alzheimer's Research & Therapy
- Published
- 2020-06-04
- Volume
- 12
- Issue
- 1
- Pages
- 69-69
- ISSN
- 1758-9193 (ISSN-L)
- PMC
- PMC7271826
- OpenAlex
- W3032981909
- Cited by
- 555
- References
- 27
- Citations by year
- 2026: 18 · 2025: 36 · 2024: 74 · 2023: 72 · 2022: 165 · 2021: 137 · 2020: 52
- FWCI
- 46.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Alzheimer s Research & Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion, cc-by)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DZNE Pub (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG059752)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Keywords
- COVID-19 pandemic, SARS-CoV-2, neurological complications, cognitive decline, long-term effects, neuroinflammation, inflammatory cytokines, neurodegenerative diseases, post-COVID cognitive impairment, mechanical ventilation
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Animals, Brain, Humans, Pneumonia, Viral, Time Factors, Coronavirus Infections, Neurodegenerative Diseases, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
